Trexquant Investment’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-38,831
| Closed | -$1.32M | – | 1576 |
|
|
2025
Q1 | $1.32M | Buy |
+38,831
| New | +$1.32M | 0.02% | 1009 |
|
|
2024
Q2 | – | Sell |
-49,787
| Closed | -$3.39M | – | 1568 |
|
|
2024
Q1 | $3.39M | Sell |
49,787
-82,598
| -62% | -$5.63M | 0.07% | 446 |
|
|
2023
Q4 | $8.29M | Buy |
+132,385
| New | +$8.29M | 0.19% | 128 |
|
|
2023
Q3 | – | Sell |
-36,113
| Closed | -$2.03M | – | 1510 |
|
|
2023
Q2 | $2.03M | Buy |
+36,113
| New | +$2.03M | 0.05% | 487 |
|
|
2022
Q3 | – | Sell |
-5,021
| Closed | -$305K | – | 1435 |
|
|
2022
Q2 | $305K | Buy |
+5,021
| New | +$305K | 0.01% | 1108 |
|
|
2021
Q2 | – | Sell |
-10,855
| Closed | -$1.32M | – | 1154 |
|
|
2021
Q1 | $1.32M | Buy |
+10,855
| New | +$1.32M | 0.12% | 220 |
|
|
2020
Q3 | – | Sell |
-6,088
| Closed | -$447K | – | 1245 |
|
|
2020
Q2 | $447K | Sell |
6,088
-41,167
| -87% | -$3.02M | 0.03% | 716 |
|
|
2020
Q1 | $2M | Sell |
47,255
-6,638
| -12% | -$282K | 0.15% | 218 |
|
|
2019
Q4 | $3.28M | Buy |
53,893
+43,529
| +420% | +$2.65M | 0.19% | 160 |
|
|
2019
Q3 | $425K | Buy |
10,364
+463
| +5% | +$19K | 0.04% | 505 |
|
|
2019
Q2 | $466K | Buy |
+9,901
| New | +$466K | 0.04% | 482 |
|
|
2019
Q1 | – | Sell |
-54,558
| Closed | -$1.56M | – | 1041 |
|
|
2018
Q4 | $1.56M | Buy |
54,558
+48,925
| +869% | +$1.4M | 0.1% | 314 |
|
|
2018
Q3 | $250K | Buy |
+5,633
| New | +$250K | 0.02% | 746 |
|
|
2018
Q2 | – | Sell |
-11,410
| Closed | -$522K | – | 953 |
|
|
2018
Q1 | $522K | Sell |
11,410
-6,875
| -38% | -$315K | 0.04% | 621 |
|
|
2017
Q4 | $429K | Buy |
+18,285
| New | +$429K | 0.05% | 574 |
|